|

Tafinlar/Mekinist Clinical Trials

1 actively recruiting trial

Also known as: Dabrafenib/trametinib

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor1
  • Cancer1

Other1 trial

Special Drug Use-results Surveillance of Tafinlar/Mekinist

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.